Larimar Therapeutics (LRMR)
(Delayed Data from NSDQ)
$7.38 USD
+0.30 (4.24%)
Updated May 28, 2024 04:00 PM ET
After-Market: $7.37 -0.01 (-0.14%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.32 | -2.63% |
Earnings Summary
For their last quarter, Larimar Therapeutics (LRMR) reported earnings of -$0.27 per share, missing the Zacks Consensus Estimate of -$0.24 per share. This reflects a negative earnings surprise of 12.50%. Look out for LRMR's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.32 per share, reflecting a year-over-year decrease of 68.42%.
Earnings History
Price & Consensus
Zacks News for LRMR
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
LRMR: What are Zacks experts saying now?
Zacks Private Portfolio Services